$1,000-A-Month Ozempic, New Weight Loss Drug, Costs $5 To Manufacture: Yale Study

Novo Nordisk's list price for a monthly package of Ozempic is $935.77 before insurance and other rebates, yet it can be manufactured for between $0.89 to $4.73 a month, according to researchers at Yale University.

Read More

No More $35 Insulin Cap? Eli Lilly, Plaintiffs Call Off $13.5M Class Action Settlement

A settlement between the drugmaker and insulin patients that would have capped patients' out-of-pocket insulin costs at $35 for 4 years has fallen apart, after an "unfavorable ruling" from the judge overseeing the case.

Read More

HHS Streamlines 340B Dispute Process To Hospitals’ Applause, Pharma’s Disappointment

The Biden administration has put the finishing touches on the steps entities covered under the 340B Drug Discount Program must take to resolve disputes with drug manufacturers. The final rule, issued by the Department of Health and Human Services (HHS) and the Health Resources and Services Administration (HRSA) this week, landed to the delight of ...

Read More

California In A Jam After Borrowing Billions To Pay Unemployment Benefits

California’s massive budget deficit, coupled with the state’s relatively high level of joblessness, has become a major barrier to reducing the billions of dollars of debt it has incurred to pay unemployment benefits. The surge in unemployment brought on by the COVID-19 pandemic pushed the state’s unemployment insurance trust into insolvency. And over the last year California’s joblessness ...

Read More

CMS Releases Rules On Wait Times And Payment Standards In Medicaid

Rule requires 80% of Medicaid Home and Community Based Services payments directly compensate workers rather than "administrative overhead."

Read More

Biden Administration Sets Higher Staffing Mandates. Most Nursing Homes Don’t Meet Them.

The Biden administration finalized nursing home staffing rules Monday that will require thousands of them to hire more nurses and aides — while giving them years to do so. The new rules from the Centers for Medicare & Medicaid Services are the most substantial changes to federal oversight of the nation’s roughly 15,000 nursing homes in more ...

Read More

Medicare’s Push To Improve Chronic Care Attracts Businesses, but Not Many Doctors

Carrie Lester looks forward to the phone call every Thursday from her doctors’ medical assistant, who asks how she’s doing and if she needs prescription refills. The assistant counsels her on dealing with anxiety and her other health issues. Lester credits the chats for keeping her out of the hospital and reducing the need for ...

Read More

A Cheap Drug May Slow Down Aging. A Study Will Determine If It Works

A drug taken by millions of people to control diabetes may do more than lower blood sugar. Research suggests metformin has anti-inflammatory effects that could help protect against common age-related diseases including heart disease, cancer, and cognitive decline. Scientists who study the biology of aging have designed a clinical study, known as The TAME Trial, to test whether metformin ...

Read More

Lawsuit Alleges Obamacare Plan-Switching Scheme Targeted Low-Income Consumers

A wide-ranging lawsuit filed Friday outlines a moneymaking scheme by which large insurance sales agency call centers enrolled people into Affordable Care Act plans or switched their coverage, all without their permission.

Read More

When Rogue Brokers Switch People’s ACA Policies, Tax Surprises Can Follow

Tax season is never fun. But some tax filers this year face an added complication: Their returns are being rejected because they failed to provide information about Affordable Care Act coverage they didn’t even know they had.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square